INDICATION

Aptensio XR® (methylphenidate HCl extended-release) is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years of age and older.


Limitations of Use
Aptensio XR is not for use in children under 6 years of age because the safety and effectiveness have not been established.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs. Keep Aptensio XR in a safe place to protect it from theft. Never give your methylphenidate to anyone else, because it may cause death or harm to them. Selling or giving away Aptensio XR may harm others and is against the law. Tell your healthcare provider if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

The Aptensio XR® Patient Access Support Program can help you with the cost of treatment

Aptensio XR® Copay Savings Card

Eligible patients pay as little as a $30 copay for their first Aptensio XR® (methylphenidate HCl extended-release) prescription and all additional refills with a monthly maximum benefit of $150.

Insurance support

Some insurance companies may require an extra step to approve a medicine. If you experience this, specialists are available to work with your insurance provider, doctor, and pharmacy to help get Aptensio XR approved.

*Aptensio XR Copay Card Program eligibility and restrictions: Uninsured patients not eligible. Void where prohibited or otherwise restricted by law. Card NOT valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other similar federal or state healthcare program, including any state pharmacy assistance program. This offer may be restricted, revoked, or modified at any time. Patients are responsible for notifying any third-party payer about any rebate or discount they receive on their prescription purchase. Void in any state where rebates are prohibited by law, taxed, or otherwise restricted. Insured patients pay as little as a $30 copay for their prescriptions with a monthly maximum benefit of $150.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs.